139 related articles for article (PubMed ID: 11954054)
41. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.
Wall JS; Gupta V; Wilkerson M; Schell M; Loris R; Adams P; Solomon A; Stevens F; Dealwis C
J Mol Recognit; 2004; 17(4):323-31. PubMed ID: 15227639
[TBL] [Abstract][Full Text] [Related]
42. Intrabody construction and expression. I. The critical role of VL domain stability.
Ohage E; Steipe B
J Mol Biol; 1999 Sep; 291(5):1119-28. PubMed ID: 10518947
[TBL] [Abstract][Full Text] [Related]
43. Improving solubility and refolding efficiency of human V(H)s by a novel mutational approach.
Tanha J; Nguyen TD; Ng A; Ryan S; Ni F; Mackenzie R
Protein Eng Des Sel; 2006 Nov; 19(11):503-9. PubMed ID: 16971398
[TBL] [Abstract][Full Text] [Related]
44. Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code.
Fellouse FA; Barthelemy PA; Kelley RF; Sidhu SS
J Mol Biol; 2006 Mar; 357(1):100-14. PubMed ID: 16413576
[TBL] [Abstract][Full Text] [Related]
45. Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins.
Navazza V; Gabba S; Alfieri A; Giorgetti S; Marchese L; Palladini G; Mattevi A; Ascari E; Caporali R; Montecucco C; Merlini G; Perfetti V
Mol Immunol; 2008 Mar; 45(5):1519-24. PubMed ID: 17949814
[TBL] [Abstract][Full Text] [Related]
46. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
[TBL] [Abstract][Full Text] [Related]
47. Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains.
Saerens D; Conrath K; Govaert J; Muyldermans S
J Mol Biol; 2008 Mar; 377(2):478-88. PubMed ID: 18262543
[TBL] [Abstract][Full Text] [Related]
48. V
Fernández-Quintero ML; Hoerschinger VJ; Lamp LM; Bujotzek A; Georges G; Liedl KR
Proteins; 2020 Jul; 88(7):830-839. PubMed ID: 31904133
[TBL] [Abstract][Full Text] [Related]
49. Structural and functional characterization of a monoclonal antibody specific for the preS1 region of hepatitis B virus.
Pizarro JC; Vulliez-le Normand B; Riottot MM; Budkowska A; Bentley GA
FEBS Lett; 2001 Dec; 509(3):463-8. PubMed ID: 11749974
[TBL] [Abstract][Full Text] [Related]
50. Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domain.
Tsybovsky Y; Shubenok DV; Kravchuk ZI; Martsev SP
Protein Eng Des Sel; 2007 Oct; 20(10):481-90. PubMed ID: 17962224
[TBL] [Abstract][Full Text] [Related]
51. Functional aspects of co-variant surface charges in an antibody fragment.
Hugo N; Lafont V; Beukes M; Altschuh D
Protein Sci; 2002 Nov; 11(11):2697-705. PubMed ID: 12381851
[TBL] [Abstract][Full Text] [Related]
52. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
53. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
54. Thermodynamics of Fab-ssDNA interactions: contribution of heavy chain complementarity determining region 3.
Komissarov AA; Deutscher SL
Biochemistry; 1999 Nov; 38(44):14631-7. PubMed ID: 10545187
[TBL] [Abstract][Full Text] [Related]
55. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
56. The antibody response to a single antigenic determinant of the tobacco mosaic virus protein (TMVP): effects of allotype-linked genes and restricted heterogeneity of the response.
Morrow PR; Rennick DM; Benjamini E
J Immunol; 1983 Dec; 131(6):2875-81. PubMed ID: 6644022
[TBL] [Abstract][Full Text] [Related]
57. Functional mapping and single chain construction of the anti-cytokeratin 8 monoclonal antibody TS1.
Holm P; Jafari R; Sundström BE
Mol Immunol; 2007 Feb; 44(6):1075-84. PubMed ID: 16989900
[TBL] [Abstract][Full Text] [Related]
58. The Antibody Light-Chain Linker Is Important for Domain Stability and Amyloid Formation.
Nokwe CN; Hora M; Zacharias M; Yagi H; John C; Reif B; Goto Y; Buchner J
J Mol Biol; 2015 Nov; 427(22):3572-3586. PubMed ID: 26408269
[TBL] [Abstract][Full Text] [Related]
59. Diversity and junction residues as hotspots of binding energy in an antibody neutralizing the dengue virus.
Bedouelle H; Belkadi L; England P; Guijarro JI; Lisova O; Urvoas A; Delepierre M; Thullier P
FEBS J; 2006 Jan; 273(1):34-46. PubMed ID: 16367746
[TBL] [Abstract][Full Text] [Related]
60. Interaction between glycosaminoglycans and immunoglobulin light chains.
Jiang X; Myatt E; Lykos P; Stevens FJ
Biochemistry; 1997 Oct; 36(43):13187-94. PubMed ID: 9341206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]